UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2022
Commission file number: 001-40231
Universe Pharmaceuticals INC
265 Jingjiu Avenue
Jinggangshan Economic and Technological Development
Zone
Ji’an, Jiangxi, China 343100
+86-0796-8403309
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Explanatory Note
Universe
Pharmaceuticals INC (the “Registrant”) is filing this current report on Form 6-K to report its financial results for the six
months ended August 16, 2022 and to discuss its recent corporate developments.
Attached
as exhibits to this current report on Form 6-K are:
| |
(1) |
the unaudited condensed interim consolidated financial statements and related notes as Exhibit 99.1; |
| |
|
|
| |
(2) |
Management’s Discussion and Analysis of Financial Condition and Results of Operations as Exhibit 99.2; |
| |
|
|
| |
(3) |
a press release dated August 12, 2022, titled “Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022” as Exhibit 99.3; and |
| |
|
|
| |
(4) |
Interactive Data File disclosure as Exhibit 101 in accordance with Rule 405 of Regulation S-T. |
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements
in this current report with respect to the Company’s current plans, estimates, strategies and beliefs and other statements that
are not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include,
but are not limited to, those statements using words such as “believe,” “expect,” “plans,” “strategy,”
“prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,”
“intend,” “seek,” “may,” “might,” “could” or “should,” and words
of similar meaning in connection with a discussion of future operations, financial performance, events or conditions. From time to time,
oral or written forward-looking statements may also be included in other materials released to the public. These statements are based
on management’s assumptions, judgments and beliefs in light of the information currently available to it. The Company cautions investors
that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in the forward-looking
statements, including but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, and other risks contained in reports filed by the company with the U.S. Securities
and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements. Actual results may differ
significantly from those set forth in the forward-looking statements.
All
such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by
the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company
disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| |
Universe Pharmaceuticals INC. |
| |
|
| Date: August 16, 2022 |
By: |
/s/ Gang Lai |
| |
|
Gang Lai |
| |
|
Chief Executive Officer |
4
false
--09-30
2022-03-31
0001809616
0001809616
2021-10-01
2022-03-31
0001809616
2022-03-31
0001809616
2021-09-30
0001809616
2020-10-01
2021-03-31
0001809616
us-gaap:CommonStockMember
2020-09-30
0001809616
us-gaap:AdditionalPaidInCapitalMember
2020-09-30
0001809616
upc:SubscriptionReceivableMember
2020-09-30
0001809616
upc:StatutoryReservesMember
2020-09-30
0001809616
us-gaap:RetainedEarningsMember
2020-09-30
0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-09-30
0001809616
2020-09-30
0001809616
us-gaap:CommonStockMember
2020-10-01
2021-03-31
0001809616
us-gaap:AdditionalPaidInCapitalMember
2020-10-01
2021-03-31
0001809616
upc:SubscriptionReceivableMember
2020-10-01
2021-03-31
0001809616
upc:StatutoryReservesMember
2020-10-01
2021-03-31
0001809616
us-gaap:RetainedEarningsMember
2020-10-01
2021-03-31
0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-10-01
2021-03-31
0001809616
us-gaap:CommonStockMember
2021-03-31
0001809616
us-gaap:AdditionalPaidInCapitalMember
2021-03-31
0001809616
upc:SubscriptionReceivableMember
2021-03-31
0001809616
upc:StatutoryReservesMember
2021-03-31
0001809616
us-gaap:RetainedEarningsMember
2021-03-31
0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-03-31
0001809616
2021-03-31
0001809616
us-gaap:CommonStockMember
2021-09-30
0001809616
us-gaap:AdditionalPaidInCapitalMember
2021-09-30
0001809616
upc:SubscriptionReceivableMember
2021-09-30
0001809616
upc:StatutoryReservesMember
2021-09-30
0001809616
us-gaap:RetainedEarningsMember
2021-09-30
0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-09-30
0001809616
us-gaap:CommonStockMember
2021-10-01
2022-03-31
0001809616
us-gaap:AdditionalPaidInCapitalMember
2021-10-01
2022-03-31
0001809616
upc:SubscriptionReceivableMember
2021-10-01
2022-03-31
0001809616
upc:StatutoryReservesMember
2021-10-01
2022-03-31
0001809616
us-gaap:RetainedEarningsMember
2021-10-01
2022-03-31
0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-10-01
2022-03-31
0001809616
us-gaap:CommonStockMember
2022-03-31
0001809616
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001809616
upc:SubscriptionReceivableMember
2022-03-31
0001809616
upc:StatutoryReservesMember
2022-03-31
0001809616
us-gaap:RetainedEarningsMember
2022-03-31
0001809616
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-03-31
0001809616
upc:UniverseHKMember
2021-10-01
2022-03-31
0001809616
upc:UniverseIncMember
2022-03-31
0001809616
upc:UniverseTechnologyMember
2022-03-31
0001809616
upc:UniverseTechnologyMember
2019-12-01
2019-12-31
0001809616
upc:JiangxiUniverseMember
2021-10-01
2022-03-31
0001809616
upc:UniverseTradeMember
2022-03-31
0001809616
upc:JiangxiMember
2022-03-31
0001809616
2021-03-25
0001809616
us-gaap:OverAllotmentOptionMember
2021-03-29
0001809616
2021-03-25
2021-03-25
0001809616
us-gaap:OverAllotmentOptionMember
2021-03-25
2021-03-25
0001809616
upc:UniverseIncMember
2021-10-01
2022-03-31
0001809616
upc:UniverseHKMember
2021-10-01
2022-03-31
0001809616
upc:UniverseHKMember
2022-03-31
0001809616
upc:UniverseTechnologyMember
2021-10-01
2022-03-31
0001809616
upc:UniverseTechnologyMember
2022-03-31
0001809616
upc:JiangxiUniverseMember
2021-10-01
2022-03-31
0001809616
upc:JiangxiUniverseMember
2022-03-31
0001809616
upc:UniverseTradeMember
2021-10-01
2022-03-31
0001809616
upc:UniverseHanheMember
2021-10-01
2022-03-31
0001809616
upc:UniverseHanheMember
2022-03-31
0001809616
2020-10-01
2021-09-30
0001809616
upc:UniversePharmaceuticalsINCMember
2022-03-31
0001809616
upc:JxRcbBankMember
2021-10-01
2022-03-31
0001809616
upc:JxRcbBankMember
2022-03-31
0001809616
us-gaap:OtherLongTermInvestmentsMember
2021-10-01
2022-03-31
0001809616
us-gaap:OtherLongTermInvestmentsMember
2020-10-01
2021-09-30
0001809616
pf0:MinimumMember
2018-04-25
2018-05-01
0001809616
pf0:MinimumMember
2019-03-25
2019-04-01
0001809616
us-gaap:BuildingMember
2021-10-01
2022-03-31
0001809616
pf0:MinimumMember
us-gaap:MachineryAndEquipmentMember
2021-10-01
2022-03-31
0001809616
pf0:MaximumMember
us-gaap:MachineryAndEquipmentMember
2021-10-01
2022-03-31
0001809616
pf0:MinimumMember
us-gaap:AutomobilesMember
2021-10-01
2022-03-31
0001809616
pf0:MaximumMember
us-gaap:AutomobilesMember
2021-10-01
2022-03-31
0001809616
pf0:MinimumMember
upc:OfficeAndElectricEquipmentMember
2021-10-01
2022-03-31
0001809616
pf0:MaximumMember
upc:OfficeAndElectricEquipmentMember
2021-10-01
2022-03-31
0001809616
us-gaap:UseRightsMember
2021-10-01
2022-03-31
0001809616
us-gaap:ComputerSoftwareIntangibleAssetMember
2021-10-01
2022-03-31
0001809616
upc:LessThan3MonthsMember
2022-03-31
0001809616
upc:LessThan3MonthsMember
2021-10-01
2022-03-31
0001809616
upc:From4To6MonthsMember
2022-03-31
0001809616
upc:From4To6MonthsMember
2021-10-01
2022-03-31
0001809616
upc:From7To9MonthsMember
2022-03-31
0001809616
upc:From7To9MonthsMember
2021-10-01
2022-03-31
0001809616
upc:From10To12MonthsMember
2022-03-31
0001809616
upc:From10To12MonthsMember
2021-10-01
2022-03-31
0001809616
upc:Over1YearMember
2022-03-31
0001809616
upc:Over1YearMember
2021-10-01
2022-03-31
0001809616
2021-09-01
2021-09-06
0001809616
2021-09-06
0001809616
us-gaap:BuildingMember
2022-03-31
0001809616
us-gaap:BuildingMember
2021-09-30
0001809616
us-gaap:MachineryAndEquipmentMember
2022-03-31
0001809616
us-gaap:MachineryAndEquipmentMember
2021-09-30
0001809616
us-gaap:AutomobilesMember
2022-03-31
0001809616
us-gaap:AutomobilesMember
2021-09-30
0001809616
upc:OfficeAndElectricEquipmentMember
2022-03-31
0001809616
upc:OfficeAndElectricEquipmentMember
2021-09-30
0001809616
us-gaap:ConstructionInProgressMember
2022-03-31
0001809616
us-gaap:ConstructionInProgressMember
2021-09-30
0001809616
us-gaap:UseRightsMember
2022-03-31
0001809616
us-gaap:UseRightsMember
2021-09-30
0001809616
us-gaap:ComputerSoftwareIntangibleAssetMember
2022-03-31
0001809616
us-gaap:ComputerSoftwareIntangibleAssetMember
2021-09-30
0001809616
upc:AmortizationExpenseMember
2022-03-31
0001809616
us-gaap:ConstructionInProgressMember
2021-06-25
0001809616
upc:ChenyuanMember
2022-03-31
0001809616
us-gaap:ConstructionInProgressMember
upc:ChenyuanMember
2022-03-31
0001809616
upc:CapitalExpenditureMember
2022-03-31
0001809616
upc:MrGangLaiMember
2021-05-06
0001809616
2021-05-06
0001809616
2021-05-01
2021-05-06
0001809616
upc:JiangxiLulingRuralCommercialBankMember
2021-06-16
0001809616
upc:JiangxiLulingRuralCommercialBankMember
2021-06-01
2021-06-16
0001809616
2021-06-01
2021-06-16
0001809616
2021-06-16
0001809616
2021-06-30
0001809616
2021-06-01
2021-06-30
0001809616
2021-03-18
0001809616
2021-03-01
2021-03-18
0001809616
upc:MaturityGreaterThan90DaysOneMember
2022-03-31
0001809616
upc:MaturityGreaterThan90DaysOneMember
2021-09-30
0001809616
upc:MaturityGreaterThan90DaysTwoMember
2022-03-31
0001809616
upc:MaturityGreaterThan90DaysTwoMember
2021-09-30
0001809616
upc:MaturityGreaterThan90DaysThreeMember
2022-03-31
0001809616
upc:MaturityGreaterThan90DaysThreeMember
2021-09-30
0001809616
upc:MaturityGreaterThan90DaysFourMember
2022-03-31
0001809616
upc:MaturityGreaterThan90DaysFourMember
2021-09-30
0001809616
upc:MrGangLaiMember
2021-10-01
2022-03-31
0001809616
upc:MsLinYangMember
2021-10-01
2022-03-31
0001809616
upc:GreatestGroupMember
2021-10-01
2022-03-31
0001809616
upc:FoshanShangyuMember
2021-10-01
2022-03-31
0001809616
upc:GreatestGroupMember
2022-03-31
0001809616
upc:GreatestGroupMember
2021-09-30
0001809616
upc:FoshanShangyuMember
2022-03-31
0001809616
upc:FoshanShangyuMember
2021-09-30
0001809616
upc:MrGangLaiMember
2022-03-31
0001809616
upc:MrsLinYangMember
2021-09-30
0001809616
country:HK
2021-10-01
2022-03-31
0001809616
country:HK
2020-10-01
2021-03-31
0001809616
country:KY
2021-10-01
2022-03-31
0001809616
country:KY
2020-10-01
2021-03-31
0001809616
country:CN
2021-10-01
2022-03-31
0001809616
country:CN
2020-10-01
2021-03-31
0001809616
upc:CustomerMember
2021-10-01
2022-03-31
0001809616
upc:CustomerMember
2020-10-01
2021-03-31
0001809616
upc:TotalRevenueMember
2021-10-01
2022-03-31
0001809616
upc:TotalRevenueMember
2020-10-01
2021-03-31
0001809616
upc:GubenYanlingPillMember
2021-10-01
2022-03-31
0001809616
upc:GubenYanlingPillMember
2020-10-01
2021-03-31
0001809616
us-gaap:AccountsReceivableMember
2021-10-01
2022-03-31
0001809616
us-gaap:AccountsReceivableMember
2020-10-01
2021-09-30
0001809616
upc:SupplierOneMember
2021-10-01
2022-03-31
0001809616
upc:SupplierTwoMember
2021-10-01
2022-03-31
0001809616
upc:SupplierOneMember
2020-10-01
2021-09-30
0001809616
upc:SupplierTwoMember
2020-10-01
2021-09-30
0001809616
upc:supplierMember
2021-10-01
2022-03-31
0001809616
upc:SupplierOneMember
2020-10-01
2021-03-31
0001809616
upc:SupplierTwoMember
2020-10-01
2021-03-31
0001809616
upc:SupplierThreeMember
2020-10-01
2021-03-31
0001809616
upc:UniverseINCMember
2022-03-31
0001809616
upc:UniverseINCMember
2020-08-07
0001809616
upc:UniverseINCMember
2020-08-02
2020-08-07
0001809616
upc:UniverseINCMember
us-gaap:CommonStockMember
2021-10-01
2022-03-31
0001809616
us-gaap:IPOMember
2021-03-25
0001809616
us-gaap:IPOMember
2021-03-29
0001809616
us-gaap:IPOMember
2021-03-25
2021-03-25
0001809616
us-gaap:IPOMember
2022-03-31
0001809616
us-gaap:IPOMember
2021-09-30
0001809616
upc:UnderwriterWarrantsMember
2022-03-31
0001809616
upc:UnderwriterWarrantsMember
2021-10-01
2022-03-31
0001809616
upc:UnderwriterWarrantsMember
us-gaap:IPOMember
2022-03-31
0001809616
upc:UnderwriterWarrantsMember
2022-03-31
0001809616
upc:CashDividendsMember
2016-09-02
2016-09-21
0001809616
upc:CashDividendsMember
2017-09-02
2017-09-13
0001809616
upc:CashDividendsMember
2018-01-28
2018-02-02
0001809616
upc:CashDividendsMember
2018-09-02
2018-09-20
0001809616
upc:CashDividendsMember
2019-02-02
2019-02-21
0001809616
upc:CashDividendsMember
2021-10-01
2022-03-31
0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember
2021-10-01
2022-03-31
0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember
2022-03-31
0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember
2021-09-30
0001809616
upc:StatutoryReserveAndRestrictedNetAssetsMember
2020-10-01
2021-09-30
0001809616
upc:PRCMember
2022-03-31
0001809616
upc:PRCMember
2021-03-31
0001809616
pf0:ChiefExecutiveOfficerMember
2021-10-01
2022-03-31
0001809616
us-gaap:CorporateMember
2021-10-01
2022-03-31
0001809616
us-gaap:CorporateMember
2020-10-01
2021-03-31
0001809616
upc:CorporateSegmentOneMember
2021-10-01
2022-03-31
0001809616
upc:CorporateSegmentOneMember
2020-10-01
2021-03-31
0001809616
upc:CorporateSegmentTwoMember
2021-10-01
2022-03-31
0001809616
upc:CorporateSegmentTwoMember
2020-10-01
2021-03-31
0001809616
upc:CorporateSegmentThreeMember
2021-10-01
2022-03-31
0001809616
upc:CorporateSegmentThreeMember
2020-10-01
2021-03-31
0001809616
upc:CorporateSegmentFourMember
2021-10-01
2022-03-31
0001809616
upc:CorporateSegmentFourMember
2020-10-01
2021-03-31
0001809616
upc:CorporateSegmentFiveMember
2021-10-01
2022-03-31
0001809616
upc:CorporateSegmentFiveMember
2020-10-01
2021-03-31
0001809616
upc:CorporateSegmentSixMember
2021-10-01
2022-03-31
0001809616
upc:CorporateSegmentSixMember
2020-10-01
2021-03-31
0001809616
pf0:ScenarioForecastMember
upc:LRCBankMember
2022-06-15
0001809616
pf0:ScenarioForecastMember
upc:LRCBankMember
2022-06-15
2022-06-15
0001809616
pf0:ScenarioForecastMember
upc:BankOfCommunicationsMember
2022-06-24
0001809616
pf0:ScenarioForecastMember
upc:BankOfCommunicationsMember
2022-06-24
2022-06-24
0001809616
us-gaap:ParentMember
2022-03-31
0001809616
us-gaap:ParentMember
2021-09-30
0001809616
us-gaap:ParentMember
2021-10-01
2022-03-31
0001809616
us-gaap:ParentMember
2020-10-01
2021-03-31
0001809616
us-gaap:ParentMember
2020-09-30
0001809616
us-gaap:ParentMember
2021-03-31
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:shares
xbrli:pure
iso4217:CNY
utr:sqm
